COCP Message Board Post 9039750 | Cocrystal Pharma Inc.
home / stock / cocp / cocp message board
fonzkji
(investorshub)
Posted on: Jan/21/2022 08:35:47
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167581795
52 week low .5504
News, Short Squeeze, Breakout and More Instantly...
-
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...
-
BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human...
-
FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitor Topline data expected in 2024 from Phase 2a influenza A human challen...